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Objective—To estimate the associations of change in immune response with preterm delivery,
omega-3 supplementation, and fish diet.
Methods—This was an ancillary study to a randomized trial of omega-3 fatty acid
supplementation for the prevention of recurrent preterm birth. In vitro maternal peripheral blood
mononuclear leukocyte production of the anti-inflammatory cytokine, interleukin-10 (IL-10), and
the proinflammatory cytokine, tumor necrosis factor-α (TNF-α), in response to stimulation with
lipopolysaccharide, was measured at 16–22 weeks of gestation (baseline) and again at 25–28
weeks of gestation (follow-up) among women with prior spontaneous preterm birth. Changes in
concentrations from baseline to follow-up (Δ) were compared separately among groups defined by
gestational age category at delivery, fish diet history, and omega-3 compared with placebo
treatment assignment with Kruskal-Wallis tests.
Results—IL-10 Δ differed by gestational age category among 292 women with paired assays.
Concentrations increased less in women delivering between 35 and 36 6/7 weeks (48.9 pg/ml)
compared with women delivering at term (159.3 pg/ml) and decreased by 65.2 pg/ml in women
delivering before 35 weeks, p=.01. TNF-α Δ also differed by gestational age category among 319
women, but the pattern was inconsistent. Those delivering between 35 and 36 6/7 weeks exhibited
decreased concentrations of TNF-α at follow-up compared with baseline (−356.0 pg/ml);
concentrations increased among women delivering before 35 weeks, and those delivering at term,
132.1 and 86.9 pg/ml, p=.03. IL-10 Δ and TNF-α Δ were unaffected by either omega-3
supplementation or fish diet.
Conclusion—Recurrent preterm birth was associated with decreased peripheral blood
mononuclear leukocyte production of IL-10 in response to a stimulus during the second trimester.
Clinical Trial Registration—Clinical Trials.gov, www.clinicaltrials.gov, NCT00135902.
Introduction
A causal link between an inflammatory response and preterm delivery is well established.
(1–4) Proinflammatory cytokines and chemokines may be central in the final common
pathway initiating labor due to not only infection but also decidual hemorrhage,
uteroplacental ischemia, cervical disease, or immunologic phenomenon.(4–9) The Th2 anti-
inflammatory cytokine, interleukin-10 (IL-10), has a significant role in the maintenance of
pregnancy. (3, 10, 11) Treatment with IL-10 in animal models of intra-amniotic infection
reduces IL-1β-induced uterine contractions, amniotic fluid concentrations of tumor necrosis
factor α, leukocyte counts and improves pregnancy outcomes. (12–14) In human studies
peripheral blood mononuclear leukocyte (PBML) production of IL-10 has been found to be
higher in the first trimester but lower at term when compared with levels in non-pregnant
controls suggesting that downregulation of IL-10 occurs as part of the inflammatory process
necessary for term labor. (15) The role of change in regulation of anti-inflammatory or pro-
inflammatory cytokine production in response to an inflammatory stimulus across gestation
in preterm birth has not been examined.
The innate immune response to a stimulus, including the balance between pro-inflammatory
and anti-inflammatory cytokines, may alter disease severity; this response may vary between
individuals because of genetic or environmental factors including dietary exposures such as
omega-3 fatty acids.. (16–20) We conducted this study to estimate the associations of
change in immune response with preterm delivery, omega-3 supplementation, and fish diet.
We selected a priori tumor necrosis factor-α (TNF-α) as the pro-inflammatory and IL-10 as
the anti-inflammatory cytokine for study based on their functions in inflammation activation
and resolution as well as preterm labor. Prior studies have demonstrated an effect of
omega-3 fatty acids on PBML production of TNF-α and IL-10. (20–22)
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The cohort consisted of women from 13 Eunice Kennedy Shriver National Institute of Child
Health and Human Development Maternal-Fetal Medicine Units Network centers enrolled
in the randomized trial of omega-3 fatty acid supplementation to prevent recurrent preterm
birth, registered at Clinical Trials.gov (NCT00135902), between January 2005 and October
2006. The methods and results of the trial have previously been published. (23) Inclusion
criteria were a documented history of at least one prior singleton preterm delivery between
20 0/7 and 36 6/7 weeks’ gestation after spontaneous preterm labor or preterm premature
rupture of the membranes, and a current singleton pregnancy. The study was approved by
the institutional review board of each clinical site and of the data coordinating center.
Women gave written informed consent for study participation and were enrolled between 16
and 21 6/7 weeks’ gestation. Participants were randomized to receive either a daily
supplement of 2,000 mg of long chain omega-3 PUFAs or matching placebo capsules. All
participants received weekly injections of 17 alpha-hydroxyprogesterone caproate (17-
OHPC, 250 mg) because of their obstetric histories of spontaneous preterm delivery. (24)
There was no difference in the rate of preterm birth between the omega-3 and placebo
groups. Fish diet histories were assessed at baseline enrollment . The four items in the food
frequency questionnaire are dark-meat fish, canned tuna, other fish and shellfish. (25)
Blood samples were collected between 16 and 22 weeks’ gestation before starting study
drug and again at the follow-up visit between 25 and 28 weeks’ gestation for cytokine
analysis. None of the women were in labor or prelabor when the samples were collected.
Samples were shipped overnight on ice to a central laboratory (Dr. Li, Division of
Inflammation Biology and Immunology, Department of Biological Sciences, Virginia
Polytechnic Institute and State University, Blacksburg, VA). Peripheral blood mononuclear
leukocytes were isolated from heparinized blood by Isolymph sedimentation (Gallard-
Schlesinger Industries, Carle Place Inc., NY) followed by centrifugation for 5 min at 200 ×
g. The pellet was resuspended at a final concentration of 5×106 cells/ml in complete RPMI
1640 medium supplemented with 10% FBS. Cells were cultured at 37°C with 5% CO2 for
24 hours. TNF-α and IL-10 secretion in cell supernatants were analyzed using Enzyme-
Linked ImmunoSorbent Assay (ELISA) kits according to manufacturer’s instructions. The
assays were performed concomitantly in separate cell culture after incubating with 100 ng/
ml lipopolysaccharide (LPS; Escherichia coli 0111:B4, Sigma Chemical Co.). Detection
limits were 1 pg/ml for IL-10 and 2 pg/ml for TNF- α. (26, 27) Samples with concentrations
below the limit of detection or otherwise out of range were excluded from the analysis
which examined change over time.
We used Wilcoxon rank-sum and chi square tests as appropriate to compare demographic
and clinical variables of women included in this ancillary study with those of women in the
trial but excluded from the ancillary study because of lack of paired samples from baseline
and follow-up. Change in inflammatory response to a stimulus was assessed by computing
the change in concentrations of IL-10 and TNF-α in the cell supernatants (after LPS
stimulation minus unstimulated) from baseline (16–22 weeks’ gestation) to follow-up (25–
28 weeks’ gestation) in paired samples from the same patients. The change in concentrations
of IL-10 and TNF-α were compared between groups defined by gestational age at delivery
(≥ 37 weeks, 35 through 36 6/7 weeks, and < 35 weeks), fish diet history (< one fish meal
per week and ≥ one fish meal per week) and treatment assignment with Kruskal-Wallis tests.
(28) We chose a priori three gestational age groups because infection and inflammation are
more frequently identified in early versus late preterm births. The number of extreme
preterm births, <28 weeks’ gestation, with paired baseline and follow-up samples was too
small for meaningful analysis as a separate group, one patient for IL-10 and two patients for
TNF-α. Fish diet history categories were selected based on our previously reported analysis
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that showed an association between low dietary intake of fish and preterm birth in the
randomized trial cohort. (29) Multivariable logistic analysis adjusting for treatment
assignment, earliest gestational age of prior preterm delivery, number of prior preterm
deliveries, smoking, race/ethnicity, body mass index and clinical center was conducted to
test the relationship between preterm birth and fish diet history for the women with paired
cytokine measurements included in this ancillary study. To adjust for multiple pair wise
comparisons of cytokine concentrations between the three groups defined by gestational age
at delivery, we used a p value of .017; otherwise, a p< .05 was selected as indicative of
significance. All comparisons were two-sided.
Results
Among the 852 women enrolled in the trial 343 had paired cytokine measurements for either
IL-10, TNF-α, or both. The median age, number of prior preterm births and distribution by
race, smoking history, or fish dietary intake did not differ between those women who had
paired measurements and those who did not. Women with paired measurements were more
likely than women without paired measurements to be in the omega-3 treatment group.
(table 1) The rate of preterm birth less than 37 weeks’ gestation for women with paired
measurements was 36.7 % and was not different from the rate for women in the trial without
paired measurements, 41.7%, p=.15.
PBML production of both cytokines increased after LPS stimulation compared with
unstimulated levels. The median (interquartile range) increase in pg/ml was 992.8 (259.9 –
1553.5) for TNF-α and 1079.5 (303.9 – 2419.6) for IL-10.
A total of 292 women had paired assays for IL-10 and 319 women had paired assays for
TNF-α. Table 2 shows the median change with range and interquartile range from baseline
to follow-up in concentrations (LPS stimulated minus unstimulated) for Il-10 and TNF-α for
the three groups defined by gestational age at delivery. The median change in concentrations
in IL-10 were different between the three groups, p = .01. The increase in IL-10 was less in
women delivering at 35–36 weeks’ gestation (48.9 pg/ml) compared with women delivering
at term (159.3 pg/ml) and decreased from baseline to follow-up among women delivering
before 35 weeks (median decrease of 65.2 pg/ml). (table 2) The pair wise comparisons
revealed the changes in concentrations were different between those delivering before 35
weeks compared to those delivering at term, p=.01 The change in median concentrations in
TNF-α from baseline to follow-up also differed between the three groups defined by
gestational age at delivery, p = .03, but the pattern was not consistent. Women delivering at
35–36 weeks’ gestation had a drop in concentrations from baseline to follow-up (median
decrease of 356.0 pg/ml). The median increase from baseline to follow-up among women
delivering at term was 86.9 pg/ml; women delivering before 35 weeks’ gestation also had an
increase, 132.1 pg/ml. (table 2) The pair wise comparisons revealed the changes in
concentrations were different between those delivering at 35–36 weeks compared to those
delivery at term, p=.01.
Similar to the findings in the trial of 852 women, the rate of preterm birth in this ancillary
study of 343 women varied by fish diet history. The rate of preterm birth < 37 weeks’
gestation was 33.7% among those who ate at least one fish meal per week and 44.4% among
those who ate less than 1 fish meal per week, p=.004 (RR=0.76; 95% CI, 0.63–0.92). This
association remained after controlling for treatment assignment, earliest gestational age of
prior preterm delivery, number of prior preterm deliveries, smoking, race/ethnicity, body
mass index and clinical center, p=.03 (OR=0.68, 95%CI 0.48–0.96). We hypothesized that
modulation of the inflammatory response may be a mechanism by which fish diet reduces
preterm birth; however, there was no difference in the change in concentrations from
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baseline to follow-up for IL-10 or TNF-α between the two groups defined by dietary fish
intake, < 1 fish meal per week versus at least one fish meal per week. (table 3). Our previous
analysis of the association between fish diet and preterm birth showed a U shaped pattern
with probability of preterm birth decreasing with increasing fish intake but then increasing
again. The protective effect of dietary fish was not observed in women eating four or more
fish meals per week. (29) Therefore, we also estimated the association between change in
IL-10 and TNF-α concentrations among three fish-diet groups: < 1 meal per week, 1–3
meals per week, and four or more meals per week. There were no differences in these
cytokine measurements among these three groups (data not shown); Il-10, p=.58; TNF-α,
p=.26. There were no differences in change in concentrations from baseline to follow-up for
IL-10 or TNF-α between the omega-3 and placebo treatment groups. (table 3)
Discussion
In this cohort of women with a prior spontaneous preterm delivery, we observed a decrease
in LPS-stimulated PBML production of IL-10 across the second trimester in women
destined to deliver before 35 weeks’ gestation. Women who subsequently delivered at term
demonstrated an increase in IL-10 production and, although women delivering late preterm
also had increased IL-10 production, the increase was less than among those delivering at
term. It is believed that IL-10 plays a role in the maintenance of pregnancy and
downregulation of IL-10 favors an inflammatory state. (15, 30, 31) IL-10 can block preterm
labor induced by intrauterine infusion of LPS in rodents (13) and IL-1β induced preterm
labor in primates. (12) In a study of 7 women either in the first trimester or at term before
labor and 7 age-matched non-pregnant controls, PBML production of IL-10 was higher than
controls in the first trimester but dropped to non-pregnant levels at term leading the
investigators to hypothesize that withdrawal of anti-inflammatory agents, including anti-
inflammatory cytokines, occurs to accelerate an inflammatory process necessary for term
labor. (15) Our data suggest this process may occur prematurely in women destined to
deliver before term.
The study results did not support our hypothesis that the different effects of fish diet and
omega-3 supplementation on preterm birth may be due to differences in modulating the
immune response. Our results are in agreement with those from a randomized clinical trial in
pregnant women for primary allergy prevention conducted in Sweden. Among 145 women,
LPS-induced TNF-α and IL-10 secretion from whole blood cultures were not different
between those receiving 2.7 grams of omega-3 PUFA supplementation daily and those
receiving placebo. (32) Although some studies in non-pregnant individuals, cell cultures,
and animal models have reported a suppressive effect of omega-3 fatty acid supplementation
on PBML production of TNF-α and a stimulatory effect on production of IL-10 (20, 23, 24),
the majority of intervention studies in humans have found no effect of omega-3
supplementation or fish consumption on cytokines or other biomarkers of inflammation.
(33–39)
Strengths of our study include a well-characterized, large cohort of women at high risk for
preterm birth. We examined the response to an inflammatory stimulus with measurement of
both an anti-inflammatory and a pro-inflammatory cytokine over time in the second
trimester with paired samples.
The weaknesses of the study must be acknowledged. The study included women with a prior
preterm delivery; therefore, the results may not be generalizable to other obstetric patients.
All women received 17 OHPC and it is unclear what effect this may have had on our study
results. Progesterone is an immunomodulator at the maternal-fetal surface, affecting
production of pro-inflammatory cytokines by macrophages and altering T-cell clone
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cytokine secretion in favor of IL-10. (402–42) The role of activation of the maternal
inflammatory response in the preterm parturition syndrome continues to be investigated. Our
data suggest a role of premature downregulation of IL-10 production and may have
implications for treatment; however, other studies across a wider gestational age range are
needed to confirm these results. Study of subgroups such as women with a shortened
cervical length in the mid trimester, women with chronic bleeding in pregnancy, and women
with multi-fetal pregnancies might offer new insight about the preterm parturition syndrome
in different clinical situations.
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Subgroup of patients entered into the randomized trial and included in this ancillary study.
IL-10, interleukin-10; TNF-α, tumor necrosis factor α.
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Table 1
Characteristics of Women With Paired Assays From Baseline and Follow-up for Either Interleukin-10, Tumor
Necrosis Factor-α, or Both Compared With Women in the Trial for Whom Paired Assays Were Not Available
Women With Paired Measurements for
IL-10, TNF-α or Both (n =343)
Women Without Paired Cytokine
Measurements (n = 509)
P *
Median age (interquartile range) 27 (23 – 32) 27 (23 – 32) .70
Racial distribution
 Non-Hispanic White 178 (51.9) 241 (47.4) .36
 Non-Hispanic Black 107 (31.2) 181 (35.6)
 Other 58 (16.9) 87 (17.1)
Median no. of prior preterm births
(interquartile range)
1 (1 – 2) 1 (1 – 2) .16
Smoked 57 (16.6) 79 (15.5) .67
Assigned to omega-3 191 (55.7) 243 (47.7) .02
Fewer than 1 fish meal per week 162 (47.2) 267 (52.5%) .13
*
Wilcoxon rank sum or chi square tests
IL-10, interleukin-10; TNF-α, tumor necrosis factor-α.
Data are n (%) unless otherwise specified.
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Table 2
Change from Baseline to Follow-up (Δ) in Peripheral Blood Mononuclear Leukocyte Production of
Interleukin-10 and Tumor Necrosis Factor-α in Response to Lipopolysaccharide (Lipopolysaccharide
Stimulated Minus Unstimulated)
Gestational Age at Delivery (Weeks)
P*
Prior to 35 35–36 37 or After
IL-10
Number of paired samples† 39 64 189
Median Δ‡ −65.2 48.9 159.3 .01
Range‡ −5394.5, 1932.4 −4020.5, 3916.8 −3868.6, 16094.4
Interquartile range‡ −1217.4, 254.3 −843.0, 563.1 −356.2, 925.2
TNF-α
Number of paired samples 48 70 201
Median Δ‡ 132.1 −356.0 86.9 .03
Range‡ −4753.5, 13008.9 −13491.8, 20640.9 −10151.3, 14578.7
Interquartile range‡ −1218.0, 817.0 −2307.5, 334.2 −964.3, 1108.2




Paired samples from the same patients at baseline and follow-up.
‡
Data are median, range, and interquartile range in pg/mL by gestational age at delivery.
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